Evidence map›Paper›PMID 33868407›Full record

ArticleCase reports in medicine2021

Off-Label Use of Intravenous Immunoglobulin with Methylprednisolone to Treat Parsonage-Turner Syndrome in a United States Marine.

Carissa M Sedlacek, Michael Leone, Adam D Foster, Amy Hinkelman

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Parsonage-Turner syndrome: a firsthand experience of an uncommon malady.American journal of neurodegenerative disease · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Carissa M SedlacekCampbell University, Jerry M. Wallace School of Osteopathic Medicine, P.O. Box, Buies Creek, NC 27506, USA.
Michael LeoneNeurology Department, Gundersen Health System, 1900 South Avenue, La Crosse, WI 54601, USA.
Adam D FosterDepartment of Anatomy, Campbell University, Jerry M. Wallace School of Osteopathic Medicine, P.O. Box 4280, Buies Creek, NC 27506, USA.ORCID https://orcid.org/0000-0002-1265-8171
Amy HinkelmanDepartment of Microbiology and Immunology, Campbell University, Jerry M. Wallace School of Osteopathic Medicine, P.O. Box 4280, Buies Creek, NC 27506, USA.ORCID https://orcid.org/0000-0001-8854-8860
Campbell University · USGundersen Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuralgic amyotrophy (NA) also known as Parsonage-Turner syndrome is an inflammatory disorder of the brachial plexus characterized by sudden, acute onset of severe pain of the arm and/or shoulder followed by muscle weakness and sensory abnormalities. Although management may involve physical therapy, immunomodulatory drugs, and analgesics, there is nothing specific for the treatment of NA. Full functional recovery can take months to years, but recurrence and/or persistence of symptoms and disability are frequent. This case reports a 22-year-old male who recovered from NA within 3 months following treatment with 1000 mg of methylprednisolone and off-label use of 0.5 g/kg of intravenous immunoglobulins (IVIG) for four consecutive days. Three years later, the patient experienced soreness and paresthesia of the shoulder following a military shooting exercise, and 0.75 g/kg of IVIG and 1000 mg of MP were prescribed for 2 consecutive days resulting in complete recovery and no recurrences to date. EMG findings, 3.5-year postinitial treatment, revealed improvement in the brachial plexopathy. This provides support for the combined use of IVIG and glucocorticoids in the treatment of NA and highlights the need for further studies investigating whether this combined treatment regimen may accelerate recovery and improve long-term outcomes for patients diagnosed with NA.

Identifiers

PMID33868407
PMCPMC8035001
OpenAlexW3141141021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.